دوام كامل

Associate Scientist Analytical Development On-site Philadelphia PACabaletta Bio (Nasdaq: CABA) is a late-stage clinical biotechnology company focused on developing and launching curative targeted cell therapies designed specifically for patients with autoimmune diseases. The CABA pla

Associate Scientist Analytical Development On-site Philadelphia PACabaletta Bio (Nasdaq: CABA) is a late-stage clinical biotechnology company focused on developing and launching curative targeted cell therapies designed specifically for patients with autoimmune diseases. The CABA pla

قدم الآن
دوام كامل

Position Title: ScientistLocation: On-Site/Philadelphia PAReports to: Jinmin LeeDepartment: Cellular Immunology PreclinicalCabaletta Bio (Nasdaq: CABA) is a late-stage clinical biotechnology company focused on developing and launching curative targeted cell therapies designed specific

Position Title: ScientistLocation: On-Site/Philadelphia PAReports to: Jinmin LeeDepartment: Cellular Immunology PreclinicalCabaletta Bio (Nasdaq: CABA) is a late-stage clinical biotechnology company focused on developing and launching curative targeted cell therapies designed specific

قدم الآن

Cabaletta Bio

دوام كامل

Job Description Manager GLP Compliance Remote- Philadelphia PAPhiladelphia PACabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseas

Job Description Manager GLP Compliance Remote- Philadelphia PAPhiladelphia PACabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseas

قدم الآن
دوام كامل

Job Description CMC Team Leader Sr. DirectorPhiladelphia PACabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases. The CABA platf

Job Description CMC Team Leader Sr. DirectorPhiladelphia PACabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases. The CABA platf

قدم الآن
دوام كامل

Director Clinical ScientistRemoteCabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases. The CABA platform encompasses two complem

Director Clinical ScientistRemoteCabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases. The CABA platform encompasses two complem

قدم الآن

Position: Vice President Market Access & Strategy CommercialPhiladelphia PA (Hybrid)Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune

Position: Vice President Market Access & Strategy CommercialPhiladelphia PA (Hybrid)Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune

قدم الآن
دوام كامل

Position: Senior Infrastructure EngineerPhiladelphia PA (Hybrid)Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases. The CABA p

Position: Senior Infrastructure EngineerPhiladelphia PA (Hybrid)Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases. The CABA p

قدم الآن